Paediatrics Department, Homerton University Hospital NHS Foundation Trust, London, UK
Paediatrics Department, Homerton University Hospital NHS Foundation Trust, London, UK.
BMJ Case Rep. 2020 Dec 17;13(12):e238361. doi: 10.1136/bcr-2020-238361.
An 8-year-old girl of African descent presented to the hospital with a headache, lethargy, pallor and 'Coca-Cola'-coloured urine. She had been admitted 11 days before with malaria, which was successfully treated with 48 hours of parenteral artesunate. Investigations revealed signs of severe haemolytic anaemia, with a haemoglobin level of 52 g/L that reached a nadir of 10 g/L within 4 hours, in addition to haemoglobinuria, hyperbilirubinaemia and raised lactate dehydrogenase levels. She was diagnosed with post-artemisinin delayed haemolysis, which is usually self-limiting but has the potential to cause severe, life-threatening anaemia 7-21 days following malaria treatment with artesunate. There was excellent response to blood transfusion, and the child made a full recovery. This case highlights the importance of providing safety netting advice regarding signs and symptoms of anaemia to patients receiving artesunate, in addition to monitoring of haemoglobin levels in the weeks after treatment.
一位 8 岁的非洲裔女孩因头痛、乏力、面色苍白和“可口可乐”色尿液就诊于医院。她在 11 天前因疟疾入院,经 48 小时的青蒿琥酯静脉注射治疗后痊愈。检查显示严重溶血性贫血的迹象,血红蛋白水平为 52g/L,4 小时内降至最低点 10g/L,此外还有血红蛋白尿、高胆红素血症和乳酸脱氢酶水平升高。她被诊断为青蒿琥酯后迟发性溶血性贫血,通常是自限性的,但有发生严重、危及生命的贫血的风险,在青蒿琥酯治疗疟疾后 7-21 天。输血反应良好,患儿完全康复。本病例强调了向接受青蒿琥酯治疗的患者提供有关贫血症状和体征的安全网建议以及治疗后数周内监测血红蛋白水平的重要性。